Why BeOne Medicines AG (ONC) stock moved
BeOne Medicines AG (ONC) shares fell 0.5% to $310.58 as of July 21, 2026, a slight decline from the prior close of $312.02. BestStocks flagged the session as a major change for ONC. No single company-specific catalyst was confirmed during the move window. Below, we break down what changed for ONC, why it matters for investors, how the stock reacted, and the catalysts on the calendar.
ONC fell 0.5% to $310.57
ONC fell 0.5% in its latest session, moving from $312.02 to $310.58.
What it means for BeOne Medicines AG investors
For BeOne Medicines AG investors, the recent signals are mixed, leaving the near-term picture neutral / mixed. On the constructive side: BeOne Medicines AG (ONC) moved +1.94% from $311.26 to $317.29 on 2026-07-16; BeOne Medicines AG (ONC) moved +1.53% from $306.56 to $311.26 on 2026-07-15, reaching a new 30-day high. Weighing against that: Negative session, down 0.5%; New SEC filing — review for material disclosures. Wall Street's consensus price target sits at $396.89, implying +27.8% upside from $310.58. Over the past 90 days analysts logged 1 upgrade and 0 downgrades. BestStocks rates the overall signal quality weak (0/100). With earnings roughly 15 days out, the next report is the most likely near-term test of the move.
ONC price reaction
ONC last traded at $310.58, down $1.45 (-0.46%) from the previous close of $312.02. The session traded on 1.2× average volume (normal), so participation was unremarkable. Over the past month the stock has ranged between $271.80 and $317.42, and it currently sits about 85% of the way up that band.
Bullish and bearish analyst opinions on BeOne Medicines AG (ONC)
The consensus analyst price target on BeOne Medicines AG (ONC) is $396.89, 27.8% above the recent $310.58. Over the past 90 days analysts logged 1 upgrade, 10 maintains, and 0 downgrades. Here is how the bullish and bearish cases on ONC line up.
The bullish case
- Wall Street's consensus price target of $396.89 implies +27.8% upside from $310.58.
- The Street's most bullish target is $451.00 (+45.2%).
- 1 analyst upgrade in the past 90 days, most recently Jefferies to Buy (2026-07-13).
- BeOne Medicines AG (ONC) moved +1.94% from $311.26 to $317.29 on 2026-07-16.
The bearish case
- Negative session, down 0.5%.
Weighing both sides, BestStocks' composite read of recent signals is roughly balanced, as the bull-versus-bear meter above shows. This is an educational summary of the bull and bear case, not investment advice.
Analyst price targets and ratings are FMP consensus figures as of Jul 21, 2026; other aggregators may differ. High and low targets show the range of estimates, not forecasts.
Previous notable changes for ONC
Frequently asked questions about ONC
Why did BeOne Medicines AG (ONC) stock move?
ONC fell 0.5% to $310.58. No single company-specific catalyst was confirmed during the move window, and it looks technical.
How much did ONC stock fall?
ONC lost 0.46% ($1.45) versus the prior close of $312.02, last trading at $310.58 on 1.2× average volume.
When is BeOne Medicines AG's next earnings date?
ONC's next earnings report is estimated for 2026-08-05 — about 15 days away.
What is the analyst price target for ONC?
The consensus analyst price target for ONC is $396.89, about 27.8% above the current $310.58. Over the past 90 days, analysts recorded 1 upgrade, 10 maintains, and 0 downgrades.
How BestStocks tracks ONC
This page is generated automatically by BestStocks' change-detection system after its price and volume cleared ONC-specific materiality thresholds, triggering an evidence check. It draws on 7 tracked change events for ONC, cross-checked against the data sources listed below. Price, volume, and market-capitalization figures are the live intraday quote as of July 21, 2026 and refresh as new information is detected; for companies with multiple share classes, market-cap figures can differ by data source. Analyst price targets and ratings are FMP consensus. This is an educational summary of what changed and why — not personalized investment advice.